News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
487,327 Results
Type
Article (8322)
Company Profile (143)
Press Release (478861)
Multimedia
Podcasts (8)
Webinars (6)
Section
Business (167038)
Career Advice (311)
Deals (25792)
Drug Delivery (13)
Drug Development (53083)
Employer Resources (14)
FDA (9805)
Job Trends (8627)
News (238743)
Policy (17961)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (496)
Accelerated approval (27)
ADA (18)
Adcomms (1)
Allergies (98)
Alliances (33271)
ALS (114)
Alzheimer's disease (993)
Antibody-drug conjugate (ADC) (343)
Approvals (10480)
Artificial intelligence (349)
ASCO (169)
Autoimmune disease (226)
Automation (30)
Bankruptcy (263)
Belgium (3)
Best Places to Work (6995)
BIO (37)
Biologics (10)
BIOSECURE Act (1)
Biosimilars (121)
BioSpace Insights (19)
Biotechnology (90)
Bispecific (2)
Bladder cancer (144)
Brain cancer (33)
Breast cancer (560)
Cancer (3918)
Cardiovascular disease (234)
Career advice (250)
Career pathing (1)
CAR-T (182)
CDC (1)
CDMO (24)
Celiac Disease (1)
Cell therapy (497)
Cervical cancer (35)
Clinical research (48309)
Collaboration (1313)
Commercialization (3)
Compensation (1544)
Complete response letters (38)
COVID-19 (767)
CRISPR (64)
C-suite (820)
Cystic fibrosis (87)
Data (5981)
Denatured (4)
Depression (107)
Dermatology (74)
Diabetes (364)
Diagnostics (4237)
Digital health (40)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (164)
Drug pricing (12)
Drug shortages (3)
Duchenne muscular dystrophy (169)
Earnings (73827)
Editorial (3)
Employer branding (2)
Employer resources (14)
Events (88289)
Executive appointments (727)
FDA (12610)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (19)
Frontotemporal dementia (24)
Funding (967)
Gene editing (126)
Generative AI (13)
Gene therapy (341)
GLP-1 (301)
Government (958)
Grass and pollen (2)
Guidances (281)
Healthcare (9382)
Hematology (96)
HIV (55)
Huntington's disease (23)
IgA nephropathy (70)
Immunology and inflammation (110)
Immuno-oncology (66)
Indications (168)
Infectious disease (961)
Inflammatory bowel disease (131)
Inflation Reduction Act (5)
Influenza (85)
Intellectual property (266)
Interviews (41)
IPO (12396)
IRA (3)
Job creations (1981)
Job search strategy (240)
JPM (2)
Kidney cancer (18)
Kidney disease (46)
Labor market (1)
Layoffs (63)
Legal (5212)
Licensing (24)
Liver cancer (46)
Longevity (20)
Lung cancer (599)
Lymphoma (262)
Machine learning (30)
Management (3)
Manufacturing (594)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8691)
Medtech (8853)
Mergers & acquisitions (14461)
Metabolic disorders (741)
mRNA (70)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (231)
Neuropsychiatric disorders (40)
Neuroscience (1892)
NextGen: Class of 2026 (3157)
Non-profit (849)
Now hiring (15)
Obesity (237)
Opinion (18)
Ovarian cancer (170)
Pain (180)
Pancreatic cancer (210)
Parkinson's disease (208)
Partnered (12)
Patents (512)
Patient recruitment (534)
Patient selection (11)
Peanut (32)
People (41461)
Peptides (3)
Pharmaceutical (31)
Pharmacy benefit managers (9)
Phase 1 (15573)
Phase 2 (21545)
Phase 3 (14630)
Pipeline (7923)
Policy (20)
Postmarket research (1577)
Preclinical (6572)
Press Release (34)
Prostate cancer (194)
Psychedelics (10)
Radiopharmaceuticals (198)
Rare diseases (603)
Real estate (3030)
Recruiting (6)
Regenerative medicine (5)
Regulatory (15103)
Reports (23)
Research institute (590)
Resumes & cover letters (45)
Rett syndrome (43)
RNA editing (6)
RSV (49)
Schizophrenia (105)
Series A (167)
Series B (123)
Service/supplier (5)
Sickle cell disease (63)
Special edition (1)
Spinal muscular atrophy (91)
Sponsored (6)
Startups (2029)
Stomach cancer (7)
Substance use disorders (16)
Supply chain (51)
Tariffs (2)
The Weekly (4)
Vaccines (339)
Venture capital (18)
Weight loss (78)
Women's health (91)
Date
Today (93)
Last 7 days (330)
Last 30 days (1557)
Last 365 days (19173)
2026 (14174)
2025 (19317)
2024 (23079)
2023 (26591)
2022 (34654)
2021 (37216)
2020 (33509)
2019 (23291)
2018 (17489)
2017 (18814)
2016 (17923)
2015 (24290)
2014 (21690)
2013 (18155)
2012 (20231)
2011 (20485)
2010 (20360)
Location
Africa (231)
Alabama (80)
Alaska (2)
Arizona (315)
Arkansas (12)
Asia (18167)
Australia (2129)
California (12493)
Canada (3279)
China (560)
Colorado (509)
Connecticut (433)
Delaware (245)
Europe (24941)
Florida (1877)
Georgia (395)
Hawaii (3)
Idaho (46)
Illinois (743)
India (55)
Indiana (327)
Iowa (16)
Japan (444)
Kansas (104)
Kentucky (32)
Louisiana (27)
Maine (26)
Maryland (1240)
Massachusetts (8171)
Michigan (315)
Minnesota (575)
Mississippi (4)
Missouri (83)
Montana (20)
Nebraska (11)
Nevada (124)
New Hampshire (60)
New Jersey (2748)
New Mexico (12)
New York (2931)
North Carolina (1323)
North Dakota (4)
Northern California (6282)
Ohio (299)
Oklahoma (14)
Oregon (16)
Pennsylvania (2324)
Puerto Rico (24)
Rhode Island (30)
South America (409)
South Carolina (78)
South Dakota (1)
Southern California (5207)
Tennessee (125)
Texas (2040)
United States (40506)
Utah (378)
Vermont (1)
Virginia (159)
Washington D.C. (40)
Washington State (963)
West Virginia (1)
Wisconsin (78)
Wyoming (1)
487,327 Results for "daiichi sankyo inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lung cancer
Merck, Daiichi Sankyo retract accelerated approval request for lung cancer ADC
Merck and Daiichi Sankyo’s withdrawal of an accelerated approval request for the antibody-drug conjugate ifinatamab deruxtecan is a “net positive” for rivals like GSK and Roche, according to RBC Capital Markets.
September 28, 2026
·
2 min read
·
Tristan Manalac
Earnings
Daiichi Sankyo shares slip after delaying annual earnings report
Daiichi Sankyo’s full-year report was originally scheduled for April 27 but has now been pushed back to May 11. That same day, the pharma expects to release its five-year business plan.
April 24, 2026
·
2 min read
·
Tristan Manalac
Antibody-drug conjugate (ADC)
Daiichi’s pipeline falls behind rivals as cash flow nears peak: analysts
With Enhertu and Datroway hitting their peak revenue and rivals flowing into the antibody-drug conjugate space, Jefferies cuts expectations for Daiichi Sankyo.
July 30, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Daiichi Sankyo Reports First Quarter Fiscal Year 2026 Financial Results
July 31, 2026
·
8 min read
Antibody-drug conjugate (ADC)
Daiichi Sankyo Dumps Next-Gen ADC From Development Pipeline
DS-9606 was supposed to be the first antibody-drug conjugate in Daiichi Sankyo’s line of anti-cancer assets to use a modified pyrrolobenzodiazepine payload.
February 3, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Daiichi Sankyo Appoints Markus Kosch to Lead Europe Business as Part of New Commercialization Organization
August 24, 2026
·
3 min read
Press Releases
Innovent Biologics and Daiichi Sankyo Enter Exclusive Agreement for VANFLYTA® Commercialization in China
August 10, 2026
·
6 min read
Press Releases
Daiichi Sankyo Appoints Ken Keller as Chief Commercialization Officer to Lead New Commercialization Unit to Accelerate Growth of Innovative Portfolio
August 24, 2026
·
7 min read
Press Releases
New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk
August 28, 2026
·
5 min read
Press Releases
DS1025 Enters Clinical Development in Patients with Advanced Solid Tumors as Novel CD25 Directed ADC in Industry-Leading ADC Portfolio of Daiichi Sankyo
August 27, 2026
·
4 min read
1 of 48,733
Next
